Evaluation of dermato-pharmacokinetics after single application of lanoconazole

Evaluation of dermato-pharmacokinetics after single application of lanoconazole - Evaluation of dermato-pharmacokinetics after single application of lanoconazole

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015368

Enrollment

Registered

2014-10-10

Start date

2014-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteer

Interventions

application of lanoconazole external medication

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: BMI: >=18.5, <28.0

Exclusion criteria

Exclusion criteria: *any skin abnormality *any drug, cosmetics, or food allergy *any abnormal findings in the following items, hematology, biochemistry, urinalysis, blood pressure, ECG, and clinical examination

Design outcomes

Primary

Measure	Time frame
pharmacokinetics parameter	—

Countries

Japan

Contacts

Public ContactHiromitsu Imai

Oita University Hospital Clinical Pharmacology Center

imaih@oita-u.ac.jp097-586-5952

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026